Revised SPC: Vemlidy (tenofovir alafenamide) film coated tablets

Following a PRAC recommendation, instruction had been added for renal monitoring (prior to and during treatment). Cessation of treatment should be considered in case of clinically significant decreases in renal function or evidence of proximal renal tubulopathy.

Source:

electronic Medicines compendium